These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

811 related items for PubMed ID: 12494894

  • 21. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 22. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
    Kleibeuker JH, de Vries EG.
    Ned Tijdschr Geneeskd; 2003 Nov 08; 147(45):2203-7. PubMed ID: 14640056
    [Abstract] [Full Text] [Related]

  • 23. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P, van der Bijl P.
    Int J Immunopathol Pharmacol; 2003 Nov 08; 16(2 Suppl):17-22. PubMed ID: 14552700
    [Abstract] [Full Text] [Related]

  • 24. Immune restoration in head and neck cancer patients via cyclooxygenase inhibition: an update.
    Lang S, Zeidler R.
    Int J Immunopathol Pharmacol; 2003 Nov 08; 16(2 Suppl):41-8. PubMed ID: 14552703
    [Abstract] [Full Text] [Related]

  • 25. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
    Sanborn R, Blanke CD.
    Semin Oncol; 2005 Feb 08; 32(1):69-75. PubMed ID: 15726508
    [Abstract] [Full Text] [Related]

  • 26. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
    Pruthi RS, Derksen E, Gaston K.
    J Urol; 2003 Jun 08; 169(6):2352-9. PubMed ID: 12771797
    [Abstract] [Full Text] [Related]

  • 27. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H, Arber N.
    Isr Med Assoc J; 2000 Sep 08; 2(9):695-702. PubMed ID: 11062772
    [Abstract] [Full Text] [Related]

  • 28. The prevention of colorectal cancer by aspirin use.
    Giovannucci E.
    Biomed Pharmacother; 1999 Aug 08; 53(7):303-8. PubMed ID: 10472428
    [Abstract] [Full Text] [Related]

  • 29. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors.
    Reddy BS, Rao CV.
    J Environ Pathol Toxicol Oncol; 2002 Aug 08; 21(2):155-64. PubMed ID: 12086402
    [Abstract] [Full Text] [Related]

  • 30. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S, Sellers LA, Cindrova T, Skepper J, Gherardi E, Sasisekharan R, Fan TP.
    Cancer Res; 2003 Dec 01; 63(23):8351-9. PubMed ID: 14678996
    [Abstract] [Full Text] [Related]

  • 31. Molecular pathology of cyclooxygenase-2 in neoplasia.
    Fosslien E.
    Ann Clin Lab Sci; 2000 Jan 01; 30(1):3-21. PubMed ID: 10678579
    [Abstract] [Full Text] [Related]

  • 32. Antioxidants reduce cyclooxygenase-2 expression, prostaglandin production, and proliferation in colorectal cancer cells.
    Chinery R, Beauchamp RD, Shyr Y, Kirkland SC, Coffey RJ, Morrow JD.
    Cancer Res; 1998 Jun 01; 58(11):2323-7. PubMed ID: 9622066
    [Abstract] [Full Text] [Related]

  • 33. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer.
    Yamamoto DS, Viale PH.
    Clin J Oncol Nurs; 2003 Jun 01; 7(1):21-9. PubMed ID: 12629931
    [Abstract] [Full Text] [Related]

  • 34. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
    Milas L.
    Am J Clin Oncol; 2003 Aug 01; 26(4):S66-9. PubMed ID: 12902859
    [Abstract] [Full Text] [Related]

  • 35. COX-2 inhibitors as radiosensitizing agents for cancer therapy.
    Davis TW, Hunter N, Trifan OC, Milas L, Masferrer JL.
    Am J Clin Oncol; 2003 Aug 01; 26(4):S58-61. PubMed ID: 12902857
    [Abstract] [Full Text] [Related]

  • 36. [Non-steroidal anti-inflammatory drugs and chemoprevention of digestive cancer].
    Wei WQ, Qiao YL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Feb 01; 23(1):78-82. PubMed ID: 12905826
    [Abstract] [Full Text] [Related]

  • 37. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control.
    Ramsay RG, Ciznadija D, Vanevski M, Mantamadiotis T.
    Int J Immunopathol Pharmacol; 2003 Feb 01; 16(2 Suppl):59-67. PubMed ID: 14552705
    [Abstract] [Full Text] [Related]

  • 38. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B, Brune K.
    Pharm Unserer Zeit; 1999 Jan 01; 28(1):21-9. PubMed ID: 10078026
    [No Abstract] [Full Text] [Related]

  • 39. The role of arachidonic acid regulatory enzymes in colorectal disease.
    Abir F, Alva S, Kaminski DL, Longo WE.
    Dis Colon Rectum; 2005 Jul 01; 48(7):1471-83. PubMed ID: 15868226
    [Abstract] [Full Text] [Related]

  • 40. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
    Elder DJ, Baker JA, Banu NA, Moorghen M, Paraskeva C.
    J Pathol; 2002 Dec 01; 198(4):428-34. PubMed ID: 12434411
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 41.